. New Ginsenosides SG1 (1) and SG2 (2) Ginseng (the root of Panax ginseng C.A. Meyer, Araliaceae) is one of the most commonly used traditional medicines in the Orient for the treatment of various diseases.
1,2 Biologically active constituents of ginseng have been pursued extensively and many dammarane-type triterpene oligoglycosides, generally known as ginsenosides, have been characterized as the principal ingredients. [1] [2] [3] [4] Traditionally, ginseng has been processed to make white ginseng (WG, roots air-dried after peeling) and red ginseng (RG, roots steamed at 98 -100 o C without peeling) to enhance its preservation and efficacy, which is associated with the changes in the chemical constituents, especially newly formed ginsenosides as results of steaming process, considerably.
Recently, there have been reported that black ginseng, which is steamed at a higher temperature (120 o C) under higher pressure (0.15 MPa), increased significantly biological effects. [5] [6] [7] Meanwhile, its constituents have been analyzed, but not extensively in respect to that of other conventional ginsengs. 7 Subsequently, in our ongoing systematic ginseng-research, the current study on chemical components of the black ginseng led to the isolation of two new saponins, named ginsenosides SG 1 (1) and SG 2 (2) (Fig. 1) , along with twenty compounds, including ginsenoside Rh2 (3), 8 20R-ginsenoside Rh1 (4), 9 ginsenoside Rk 3 (5), 10 ginsenoside Rh 4 (6), 10 6'-acetyl ginsenoside Rg 1 (7), 11 ginsenoside Rg 6 (8), 12 20E-ginsenoside F 4 (9), 13 ginsenoside Rg 2 (10), 14 ginsenoside Rg1 (11), 15 ginsenoside Rf (12), 16 ginsenoside Rg 3 (13) , 17 ginsenoside Rk 1 (14) , 10 6'''-acetyl ginsenoside Re (15), 11 ginsenoside Re (16), 15 ginsenoside Rs 2 (17), 18 ginsenoside Rd (18) , 15 ginsenoside F3 (19), 15 ginsenoside Rb1 (20), 15 ginsenoside Rc (21), 15 and ginsenoside Rb 2 (22) 15 ( Fig. 2) . Ginsenoside SG 1 (1) , an amorphous powder, has the molecular formula C36H62O10 deduced by a high-resolusion electrospray- C-NMR data of 1 were similar to those of 20R-ginsenoside Rh 1 9 except for the signals belonging to the side-chain part (C-22 -C-27) of the aglycone. The structure of 1, especially the side-chain, was assigned by was proposed as E form based on the 13 C-NMR agreements of C-24, 26, and 27 with those in the literature 15 and, furthermore, the NOE correlation H-26/H-24 in the ROESY spectrum of 1 (Fig. 4) . On the basis of the above evidence, the structure of ginsenoside SG 1 (1) was characterized as (20R,24E)-3β,6α,12β, 20α,26-pentahydroxydammar-24-ene 6-O-β-D-glucopyranoside.
Notes
Ginsenoside SG 2 (2), also an amorphous powder, has the molecular formula C 36 H 62 O 11 on the basis of HR-ESI-TOF-MS experiment. Compound 2 was proposed to have a hydroperoxyl group due to positive response to N,N-dimethyl-p-phenylenediammonium dichloride reagent. 4 On the acid hydrolysis, it yielded D-glucose as identified by the GC procedure. The 1 Hand 13 C-NMR (Table 1 ) spectra of 2 due to the dammarane-type triterpene part and 6-O-β-D-glucopyranosyl moiety were superimposable on those of 20S-ginsenoside Rh1 10 except for the signals of the side-chain part (C-24 -C-27), which was identical to that of floralginsenosides A and C. 4 20S-Configuration was suggested based on the 13 C-NMR evidence of C-17 at δ 54.5 and C-21 at δ 27.0, which were downfield-shifted as compared with those of ginsenoside SG 1 (1) and other ginsenosides with 20R-configuration. 8, 9 Moreover, comprehensive analyses of the 1 H-1 H COSY, HMQC, and HMBC (Fig. 3) permitted complete assignments of its NMR data as well as partial structures. As shown in Fig. 3 , interpretation of the 1 H-1 H COSY spectra indicated the connectivity of partial structures written in bold lines, with key HMBC correlations observed between the following protons and carbons: H-6 and C-8; H-12 and C-9, 17; H-18 and C-7, 9, 14; H-19 and C-1, 5, 9; H-21 and C-22; H-22 and C-24; H-24 and C-22, 26; H-26 and C-24, 27; H-1' and C-6. Hence, the structure of ginsenoside SG2 (2) was identified as (20S)-24ξ-hydroperoxyl-3β,6α,12β,20β-tetrahydroxydammar-25-ene 6-O-β-D-glucopyranoside.
In conclusion, the present study demonstrates that steaming of ginseng at higher temperatures produces significant changes in its chemical constituents, especially with formation of unique minor components. Biological evaluation of ginsenosides from black ginseng is now in progress.
Experimental
General procedures. Optical rotations were obtained using a DIP-360 digital polarimeter (Jasco, Easton, MD). IR spectra were measured using a Perkin-Elmer 577 spectrometer (Perkin Elmer, Waltham, MA). NMR spectra were recorded on Bruker DRX 400 and 500 NMR spectrometers (Bruker, Billerica, MA). ESI-MS spectra were recorded on a Model 1100 LC-MSD Trap spectrometer (Agilent, Santa Clara, CA). HRESITOFMS measurements utilized a JEOL AccuTOF TM LC mass spectrometer (Jeol, Tokyo, Japan). GC (Shimadzu-2010, Tokyo, Japan) using a DB-05 capillary column (0. Plant material. The ginseng roots were collected in Geumsan province, which is well-known for ginseng cultivation in Korea, in August 2008, and were taxonomically identified by one of us (Young Ho Kim). Voucher specimens (CNU 08202) have been deposited at the College of Pharmacy, Chungnam National University. The air-dried sample (2.0 kg) was then steamed at 120 o C for 4 h under 0.15 MPa pressure, without mixing with water, to give the steamed sample, which was used for extraction and isolation in this study.
Extraction and isolation. The black ginseng sample was extracted in MeOH (5.0 L × 3, 50 o C) and the combined extracts were concentrated in vacuo to dryness. The MeOH residue (650 g) was suspended in H 2 O (2.5 L), then partitioned with CH 2 Cl 2 (2.5 L × 3), and the water layer was subjected to a Diaion HP-20 column eluted with a gradient of MeOH in H2O (25, 50, 75, and 100% MeOH; v/v) to give six fractions (fr. 1.1 -fr. 1.6). Next, fr. 1.3 (40 g) was chromatographed on a silica gel column using CH2Cl2-MeOH (20:1-1:1) to afford eight subfractions (fr. 2.1 -fr. 2.8). Fr. 2.3 (1.3 g) was further chromatographed on a silica gel column with CHCl 3 -MeOH-H 2 O (7:1: 0.1), followed by a reversed-phase (RP) column with MeOH-H 2 O (2:1) to obtain ginsenoside SG 1 (1, 18 mg) 20R-ginsenoside Rh 1 (4, 120 mg), ginsenoside Rk 3 (5, 35 mg), and ginsenoside Rh4 (6, 25 mg). Fr. 2.5 (6.5 g) was rechromatographed on a silica gel column with CHCl 3 -MeOH-H 2 O (4:1:0.1) to afford nine subfractions (fr. 3.1 -fr. 3.9). Next, fr. 3.3 (420 mg) was subjected to a silica gel column with CHCl3-MeOH-H2O (4:1: 0.1), followed by a RP column with MeOH-H 2 O (5:2) to furnish ginsenoside SG 2 (2, 6 mg), ginsenoside Rg 1 (7, 100 mg), and ginsenoside Rg3 (13, 7 mg) . Similarly, fr. 3.5 (680 mg) was repeatedly chromatographed on a silica gel column with CHCl 3 -MeOH-H 2 O (4:1:0.1), followed by a RP column with MeOH-H2O (3:1) to give ginsenoside Rh2 (3, 11 mg), ginsenoside Rg1 (11, 4 mg), and ginsenoside Rf (12, 44 mg). Again, fr. 3.6 (800 mg) was chromatographed on a a silica gel column with CHCl 3 -MeOH-H2O (4:1:0.1), followed by a RP column with MeOH-H 2 O (2:1) to afford 6'''-acetyl ginsenoside Re (15, 8 A solution of each compound (2.0 mg) in 1.0 M HCl (4.0 mL) was heated under reflux for 4 h. Then, the reaction mixture was concentrated in vacuo to dryness. The residue was extracted with EtOAc and H2O (5 mL each, 3 times). Next, the sugar residue, obtained by concentration of the water layer, was dissolved in dry pyridine (0.1 mL). Then L-cysteine methyl ester hydrochloride in pyridine (0.06 M, 0.1 mL) was added to the solution. After heating the reaction mixture at 60 o C for 2 h, 0.1 mL of trimethylsilylimidazole was added. Heating at 60 o C was continued for a further 2 h, and the mixture was evaporated in vacuo to give a dried product, which was partitioned between hexane and H 2 O. 6 The hexane layer was analyzed by the GC procedure (General Procedures). The peak of the hydrolysate of the compound was detected at t R 14.12 min for D-glucose. The retention times for the authentic samples (Sigma), after being treated in the similar manner, were 14.12 min (D-glucose) and 14.25 min (L-glucose), respectively. Co-injection of the hydrolysates of the ginsenoside with standard D-glucose gave single peaks.
